Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US08/440,570external-prioritypatent/US5510381A/en
Application filed by Warner Lambert CofiledCriticalWarner Lambert Co
Publication of NZ336662ApublicationCriticalpatent/NZ336662A/en
Acyclic And Carbocyclic Compounds In Medicinal Compositions
(AREA)
Abstract
The compounds of formula I, wherein R1 is H or C1-8 alkyl and n is 4 to 6, may be used in the preventative treatment of bipolar disorder and in the treatment of mania in its various forms (acute or chronic, single or recurring episodes). The preferred compound of formula I is gabapentin.
NZ336662A1995-05-151996-04-26Treatment of mania and bipolar disorder with gabapentin
NZ336662A
(en)